Incidence of amenorrhea and premature ovarian failure in women who underwent uterine fibroid embolization: single centre study
Downloads
Purpose: To retrospectively determine the incidence of amenorrhea and premature ovarian failure in women who underwent uterine fibroid embolization (UFE) in King Fahad Specialist Hospital in Dammam (KFSH-D).
Patients and methods: All women who had undergone UFE in KFSH-D from August 2007 to October 2015 were included for a total of 82 patients. Follow up consisted of a questionnaire inquiring about symptoms, improvement after the procedure and whether menstruation resumed or not. The pre-procedure and post-procedure pelvis MRI as well as UFE images and reports were reviewed for all patients.
Results: One patient (1.5 %) was found to have amenorrhea out of the 67 patients we were able to contact. She was 52 years old at the time of UFE and had irregular period. Menstruation did not resume following UFE along with menopausal symptoms including night sweats, mood swings and irritability, likely due to premature ovarian failure (POF). The rest of patients had normal resumption of menses.
Conclusion: The incidence of amenorrhea is less than what’s reported in the literature could be due to advances in UFE since its introduction as a treatment for uterine fibroids, likely due to advances in image quality, tans-catheter embolization equipments/techniques and embolic material used in UFE.
Downloads
Ahmad A, Qadan L, Hassan N, Najarian K. Uterine artery embolization treatment of uterine fibroids: Effect on ovarian function in younger women. J Vasc Interv Radiol. 2002;13(10):1017-1020.
Carrillo TC. Uterine artery embolization in the management of symptomatic uterine fibroids: An overview of complications and follow-up. Semin Intervent Radiol. 2008;25(4):378-386.
Gainey Seals J, Jones PA, Wolfe C. Uterine artery embolization as a treatment for symptomatic uter-ine fibroids: A review of literature and case report. J Am Acad Nurse Pract. 2006;18(8):361-367.
Hald K, Klow NE, Qvigstad E, Istre O. Laparoscopic occlusion compared with embolization of uter-ine vessels: A randomized controlled trial. Obstet Gynecol. 2007;109(1):20-27
Katsumori T, Kasahara T, Akazawa K. Long-term outcomes of uterine artery embolization using gelatin sponge particles alone for symptomatic fibroids.
Hovsepian DM, Siskin GP, Bonn J, et al. Quality improvement guidelines for uterine artery emboli-zation for symptomatic leiomyomata. Cardiovasc Intervent Radiol. 2004;27(4):307-313.
Joffre F, Tubiana JM, Pelage JP, Groupe FEMIC. FEMIC (fibromes embolises aux MICrospheres calibrees): Uterine fibroid embolization using tris-acryl microspheres. A french multicenter study. Cardiovasc Intervent Radiol. 2004;27(6):600-606.
Chrisman HB, Saker MB, Ryu RK, et al. The impact of uterine fibroid embolization on resumption of menses and ovarian function. J Vasc Interv Radiol. 2000;11(6):699-703.
Lanciego C, DiazPlaza I, Ciampi J, et al. Utero-ovarian anastomoses and their influence on uterine fibroid embolization. Journal of Vascular & Interventional Radiology. 2012;23(5):595-601.
Katsumori T, Nakajima K, Mihara T, Tokuhiro M. Uterine artery embolization using gelatin sponge particles alone for symptomatic uterine fibroids: Midterm results. American Journal of Roentgenolo-gy. 2002;178(1):135-139.
Edwards RD, Moss JG, Lumsden MA, et al. Uterine-artery embolization versus surgery for sympto-matic uterine fibroids. N Engl J Med. 2007;356(4):360-370.
Katsumori T, Kasahara T, Tsuchida Y, Nozaki T. Amenorrhea and resumption of menstruation after uterine artery embolization for fibroids. Int J Gynaecol Obstet. 2008;103(3):217-221.
Copyright (c) 2021 International Journal of Scientific Research and Management
This work is licensed under a Creative Commons Attribution 4.0 International License.
